123 related articles for article (PubMed ID: 38350260)
1. Response to "lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid".
Akhtar A; Akhtar R; Zaidi E
Oral Oncol; 2024 Mar; 150():106718. PubMed ID: 38350260
[No Abstract] [Full Text] [Related]
2. Comment on: Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
Xu R
Oral Oncol; 2024 May; 152():106767. PubMed ID: 38579477
[No Abstract] [Full Text] [Related]
3. Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
Hei H; Luo Z; Zheng C; Gong W; Zhou B; Fang J; Qin J
Oral Oncol; 2023 Nov; 146():106563. PubMed ID: 37690364
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.
Lindfors H; Karlsen M; Karlton E; Zedenius J; Larsson C; Ihre Lundgren C; Juhlin CC; Shabo I
Sci Rep; 2023 Jan; 13(1):1070. PubMed ID: 36658256
[TBL] [Abstract][Full Text] [Related]
5. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
[TBL] [Abstract][Full Text] [Related]
6. In Reference to: How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Megwalu UC
Laryngoscope; 2023 Mar; 133(3):E21. PubMed ID: 36271915
[No Abstract] [Full Text] [Related]
7. Sentinel Lymph Node Biopsy Status Correlates with Postoperative Stimulated Thyroglobulin Levels in Low-risk Papillary Thyroid Cancer Patients.
Saliba J; Payne RJ; Varshney R; Sela E; Maniakas A; Rahme E; Mlynarek A; Caglar D; Hier MP; Tamilia M
Endocr Pract; 2014 May; 20(5):399-404. PubMed ID: 24325994
[TBL] [Abstract][Full Text] [Related]
8. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Lymph Node Compartments in Papillary Thyroid Cancer.
Sturgeon C; Yang A; Elaraj D
Surg Oncol Clin N Am; 2016 Jan; 25(1):17-40. PubMed ID: 26610772
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin washout from cervical lymph node fine needle aspiration biopsies in patients with differentiated thyroid cancer: an analysis of different expressions to use in post-total thyroidectomy follow-up.
Kahramangil B; Kose E; Donmez M; Aydin H; Reynolds JP; Krishnamurthy V; Jin J; Shin J; Siperstein A; Berber E
Surgery; 2020 Jan; 167(1):34-39. PubMed ID: 31495510
[TBL] [Abstract][Full Text] [Related]
11. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
12. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
13. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
[TBL] [Abstract][Full Text] [Related]
14. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract][Full Text] [Related]
15. Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.
Zhao H; Wang Y; Wang MJ; Zhang ZH; Wang HR; Zhang B; Guo HQ
BMC Cancer; 2017 Apr; 17(1):296. PubMed ID: 28454525
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
[TBL] [Abstract][Full Text] [Related]
18. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
[TBL] [Abstract][Full Text] [Related]
20. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
